<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/feed.rss.xml" type="text/xsl" media="screen"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Axis Clinicals USA</title>
    <description>AXIS Clinicals USA is a trusted early-phase CRO helping pharmaceutical and biotech companies accelerate drug development. With expertise in Phase I trials and clinical research, we deliver safe, efficient, and compliant study execution as a true strategic partner.</description>
    <link>https://speakerdeck.com/axisclinicals</link>
    <atom:link rel="self" type="application/rss+xml" href="https://speakerdeck.com/axisclinicals.rss"/>
    <lastBuildDate>2026-09-25 07:05:05 -0400</lastBuildDate>
    <item>
      <title>Bioequivalence Studies: When Are They Needed in Drug Development?</title>
      <description>Bioequivalence studies help determine whether a test drug performs similarly to a reference product. Learn when these studies are needed, how PK data are used, and their role in generic drug development and clinical research.</description>
      <media:content url="https://files.speakerdeck.com/presentations/a28629ab27324a7596134fc0162d117b/preview_slide_0.jpg?40677607" type="image/jpeg" medium="image"/>
      <content:encoded>Bioequivalence studies help determine whether a test drug performs similarly to a reference product. Learn when these studies are needed, how PK data are used, and their role in generic drug development and clinical research.</content:encoded>
      <pubDate>Fri, 25 Sep 2026 00:00:00 -0400</pubDate>
      <link>https://speakerdeck.com/axisclinicals/bioequivalence-studies-when-are-they-needed-in-drug-development</link>
      <guid>https://speakerdeck.com/axisclinicals/bioequivalence-studies-when-are-they-needed-in-drug-development</guid>
    </item>
  </channel>
</rss>
